Orchestra BioMed
Jason Aryeh is the current Director at Orchestra BioMed. Prior to this, they served as the Director of the Cystic Fibrosis Foundation Therapeutics Board from February 2011 to February 2018. Jason has also been a Member Board of Advisors for the Accreditation Council for Medical Affairs (ACMA) since August 2018. Before their work with Orchestra BioMed and the Cystic Fibrosis Foundation, Jason was the Managing General Partner at JALAA Equities, LP.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Orchestra BioMed
Orchestra BioMed is a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine. The company partners with established market leaders to drive the global commercialization of its products, establishing multiple long-term potential revenue streams and supporting further product development.